Provider: MizMedi Hospital—Seoul National University
Cell line no longer eligible for federal funding.
MizMedi Hospital—Seoul National University Registered Cell Lines (Korea)
NIH Code
| MI01* |
Provider's Code |
(Miz-hES1)* |
Embryo |
Patient's Consent |
Yes |
IRB Approvals |
Yes |
Source |
IVF Clinic |
Category |
Frozen embryo |
IVF Status |
Surplus, to be discarded |
Characteristics |
Passages |
125 |
Teratoma Foundation |
Three germ layer |
Embryoid Body |
Three germ layer |
DNA Fingerprinting |
TBD |
Karyotype |
Normal 46 XY |
Stem Cell Immuno Markers: |
|
SSEA-1 |
- |
SSEA-3 |
Partially + |
SSEA-4 |
+ |
TRA 1-60 |
+ |
TRA 1-81 |
+ |
Oct-4 |
+ |
Alkaline Phosphatase |
+ |
Gender |
Male |
Frozen/Thawed: |
|
Short-Term |
Yes |
Long-Term |
Yes |
Pluripotent |
Yes |
Commercialization |
Available |
1,000 |
Price |
$5,000 |
# Shipped |
39 |
TBD = To be Determined
* Cell line no longer eligible for federal funding.
In your grant applications please use the NIH codes, rather than the providers' codes, to identify the cell lines.
Information about the cell line comes from the provider and has not been independently verified by the NIH.
For any questions about the registry, please e-mail stemcell@mail.nih.gov.